baber/WOPTO huggingface dataset:
Patent NZ-506431-A (NZ)
Title: Radio transmitter receiver transceiver system for recording interactions between animals
Inventor: CLOUT MICK
IPC: H04B1/38
Filed: 2000-08-18
Abstract: A method for recording interactions between animals comprising the steps of fitting a transmitter, receiver or transceiver to each animal in a group of animals to be monitored.  Each transmitter or transmitter part of each transceiver being arranged to produce a signal comprising a code unique to that device and each receiver or receiver part of each transceiver being arranged to operate in a low power mode in isolation.  Upon detecting a signal from a transmitter or transceiver the receiver or receiver part of each transceiver operates in a higher power mode.    The date or date and time of the detection of a code produced by a transmitter or transceiver and information identifying the transmitter or transceiver is then stored.   The animals are allowed freedom to interact for a predetermined time.  The animals fitted with a receiver or transceiver are subsequently re-captured, the receiver or transceiver fitted to the animals removed, and the information recorded on the transceivers and/or receivers downloaded into a computer. The downloaded information is processed to provide data showing the interaction between animals.
Patent NZ-507104-A (NZ)
Title: Dairy product and process for making cheese containing gum
Inventor: JOHNSTON KEITH
IPC: A23L35/00
Filed: 2000-09-22
Abstract: A process for making cheese, specifically mozzarella, where a gum preparation is added to the starting milk composition before pasteurization, the starting milk composition having a fat content of more than 0.3%.  The milk is then ripened by a starter culture and/or acid to produce cheese milk that is then coagulated.  The coagulum is cut to drain away the whey from the curd, the curd then being shaped and cooled or heated, stretched, extruded, molded and cooled.  Another alternative to the process is to add the gum to the pre-pasteurized milk composition.  The addition of the gum to the starting milk composition results in an increase in moisture content and additional desirable melt and sensory characteristics.
Patent NZ-508617-A (NZ)
Title: BASB027 proteins and genes from Moraxella Catarrhalis, antigens, antibodies, and uses
Inventor: VINALS-BASSOLS CARLOTA
IPC: C07K14/21
Filed: 1999-05-31
Abstract: Isolated polypeptides of Moraxella catarrhalis bacteria (commonly found in the human respiratory tract) comprising amino acid sequences selected from SEQ ID Nos. 1-4, and their use in treating Moraxella catarrhalis infections.
Patent NZ-513222-A (NZ)
Title: Storage system and apparatus
Inventor: CHAPMAN PETER RICHARD
IPC: B65D90/14
Filed: 2001-07-31
Abstract: A materials handling apparatus for storing and transporting materials and wherein the apparatus can be disassembled in part after use.  The apparatus includes a substantially horizontal platform attached to and supported by at least four spaced apart corner base members to define a base.  Each respective corner base member is adapted to locate a corner extension member in a substantially vertically disposed orientation.  Each corner base member is provided with a foot at the lower end portion, each foot projecting beneath the platform to enable the platform to be elevated.  Each foot is adapted, in use, to locate and secure the top end portion of a second vertically disposed corner extension member or the top end portion of a second apparatus below.
Patent NZ-516783-A (NZ)
Title: Tricyclic monosaccharide derivatives useful in treating acute ischemia-induced neurodegeneration
Inventor: COSTANZO MICHAEL
IPC: A61K31/357
Filed: 2000-07-20
Abstract: Use of a compound of formula (I) wherein X is methylene or oxygen; R1 and R2 are the same or different and chosen from hydrogen, C1-C6 alkyl, C3-C6 cycloalkyl, benzyl, allyl, and C1-C6 perfluoroalkylmethyl, or taken together as N2 to define an azide group; R3 and R4 are the same or different and chosen from hydrogen and C1-C6 alkyl; and R5 and R6 may be the same or different and are selected from oxygen, a lone pair of electrons and NR7; wherein R7 is elected from hydrogen, C1-C6 alkyl, C1-C6 perfluoroalkyl, arenesulfonyl, C1-C6 alkoxycarbonyl and arenemethyloxycarbonyl; or a pharmaceutically acceptable salt thereof; in the preparation of a medicament for the treatment of ischemia-induced neurodegeneration in a mammal in need thereof.
Patent NZ-517779-A (NZ)
Title: Internet auctioning of items with restricted transferability
Inventor: FRASER STUART A
IPC: G06Q50/12
Filed: 2000-09-28
Abstract: An electronic trading system for enabling a first consumer to transfer an item with restricted transferability to a second consumer includes a provider system 4, and transfer system 2, computers 3, 5 operable by the first and second consumers and a communication network for the transmission of data or messages between the parts of the system. The transfer system is configured to receive, from the first consumer, a request 8 to transfer an item after having purchased the item from a provider. An authorisation request 9 to transfer the item is sent to the provider. This request may indicate inducements to the provider to authorize the transfer. If the transfer is authorized, information 12 regarding the item is presented to other consumers, in particular the second consumer. This information may be presented as part of a bidding interface or as part of an advertising interface. Once the second consumer submits a winning bid 13 for the item when the information is presented in a bidding interface, or an acceptable offer when the information is presented in an advertising interface, the transfer of the item can then be completed with or without the assistance of an intermediary. When the transfer is completed without the assistance of an intermediary, the first and second consumer may directly transfer the item 14 and payment 15 to each other. When the transfer is completed with the assistance of an intermediary 2, the first consumer may send 16 the item to the intermediary and the second consumer may send payment 17 to the intermediary. Once both the item and the payment have been received at the intermediary, the intermediary may send 19 the item to the second consumer and all or part of the payment 18 to the first consumer.
Patent NZ-519239-A (NZ)
Title: Bandage for wound or incision closure
Inventor: LEBNER MICHAEL
IPC: A61B17/08
Filed: 2000-11-28
Abstract: Disclosed is a bandage (1) for closing a wound or incision, and methods for the use of same. The bandage comprises a first flat flexible component (5) having adhesive on a lower surface and a plurality of first elongated connectors extending from one edge thereof in a first direction. The bandage further comprises a second flat flexible component (25) having adhesive on a lower surface and one or more second elongated connectors (35) extending from one edge thereof in a second direction generally opposite to the first direction. Pulling elements (40) are provided for attaching the first elongated connectors to the second flat flexible component and the second elongated connectors to the first flat flexible component.
Patent NZ-524124-A (NZ)
Title: Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor
Inventor: KARARLI TUGRUL T
IPC: C07D237/04
Filed: 2001-08-17
Abstract: A molded article, such as a tablet, for administration to an oral cavity of a subject to treat of prevent a cyclooxygenase-2 mediated condition, disorder or disease, the molded article comprising a moldable blend of a selective cyclooxygenase-2 inhibitory drug which may have the structure of general formula (I), with a pharmaceutically acceptable excipient carrier system consisting predominantly of one or more carbohydrates, wherein: (a) the selective cyclooxygenase-2 inhibitory drug is present in a total amount of about 20% to about 60% by weight of the molded article; (b) ingredients and amounts thereof in the molded article and a process for preparing the molded article are selected such that the molded article exhibits rapid disintegration in the oral cavity; and (c) the moldable blend in prepared by a process step not requiring wet granulation; a process for preparing the molded article; and the use of the molded article in the manufacture of a medicament for treating a medical condition or disorder in a mammalian subject where treatment with a cyclooxygenase-2 inhibitor is indicated.
Patent NZ-527092-A (NZ)
Title: Data transfer and/or transformation system and method using meta data descriptors
Inventor: GARDEN PETER WILLIAM
IPC: G06F17/00
Filed: 2002-01-18
Abstract: A computer implemented method of processing data comprises the steps of :- (a) Defining meta-data descriptors to represent the data; (b) In an interactive user application defining a process associated with at least one of the meta-data descriptors; and (c) Processing the data in accordance with the defined process.
Patent NZ-527248-A (NZ)
Title: Triazolo[4,5-d) pyrimidine derivatives and their use as purinergic receptor antagonists
Inventor: GILLESPIE ROGER JOHN
IPC: A61K31/198
Filed: 2002-01-10
Abstract: Disclosed herein is the use of a compound of formula (I): wherein R1 is selected from H, alkyl, aryl, alkoxy, aryloxy, alkylthio, arylthio, halogen, CN, NR5R6, NR4COR5, NR4CONR5R6,NR4CO2R7 and NR4SO2R7; R2 is selected from aryl attached via an unsaturated carbon; R3 is selected from H, alkyl, COR5, CO2R7, CONR5R6, CONR4NR5R6 and SO2R7; R4, R5 and R6 are independently selected from H, alkyl and aryl or where R5 and R6 are in an NR5R6 group, R5 and R6 may be linked to form a heterocyclic group, or where R4, R5 and R6 are in a (CONR4NR5R6) group, R4 and R5 may be linked to form a heterocyclic group; and R7 is selected from alkyl and aryl, or a pharmaceutically acceptable salt thereof or prodrug thereof, in the treatment or prevention of a disorder in which the blocking of purine receptors, particularly adenosine receptors and more particularly A2A receptors, may be beneficial, particularly wherein said disorder is a movement disorder such as Parkinson's disease or said disorder is depression, cognitive or memory impairment, acute or chronic pain, ADHD or narcolepsy, or for neuroprotection in a subject; compounds of formula (I) for use in therapy; and the compounds of formula (I) per se.
Patent NZ-527985-A (NZ)
Title: Catheter for uniform delivery of medication
Inventor: DENIEGA JOSE CASTILLO
IPC: A61M25/00
Filed: 2000-07-19
Abstract: A catheter for the uniform delivery of fluid throughout an anatomical region, comprising: an elongated tube having a closed distal end and a plurality of exit holes in side walls of said tube, said exit holes provided along a length of said tube defining an infusion of section of said catheter, said tube being sized to be inserted into an anatomical region; and an elongated member positioned within said tube, said member being sized so that an annular space is formed between said tube and said member, said member being formed of a porous material; wherein said catheter is configured so that a fluid introduced into a proximal end of said tube will flow through said exit holes at a substantially uniform rate throughout said infusion section. (62) Divided out of 516785
Patent NZ-528070-A (NZ)
Title: Caloporoside derivatives, methods for the production thereof and their use
Inventor: EDER CLAUDIA
IPC: A61P35/00
Filed: 2002-02-23
Abstract: Caloporoside derivatives of formula (I) are disclosed, in which: R1, R2, R3 are independently of one another, H or acyl radicals having 1 to 10 carbon atoms; and R4 is H or -C(O)(CH2)nCOOH in which n is 1 to 7; with the exception that R1, R2, R3 and R4 are not all H; and the physiologically tolerated salts thereof. The process for the preparation of these compounds, which comprises fermentation of the microorganism Gloeoporus dichrous (Fr.:Fr) Bres. ST001714, DSM 13784, or one of its variants or mutants under suitable conditions, isolation of one or more of the caloporoside derivatives and conversion thereof where appropriate into physiologically tolerated slats, is also disclosed. The compounds disclosed are suitable for use as a CDK inhibitor and are useful in the treatment of cancer or other disorders with a pathological disturbance of cellular proliferation.
Patent NZ-529566-A (NZ)
Title: Dental restorative materials
Inventor: REYNOLDS ERIC CHARLES
IPC: A61K6/891
Filed: 2002-05-21
Abstract: A composition for dental restoration comprising of dental restorative material and an effective amount of casein phosphopeptide(CPP)-amorphous calcium phosphate (ACP) complex or casein phosphopeptide(CPP)-amorphous calcium fluoride phosphate (ACFP) complex. The dental restorative material is dental cement. This composition can be used for the treatment and/or prevention of dental caries in animals.
Patent NZ-530755-A (NZ)
Title: Use of ozone to whiten teeth
Inventor: LYNCH EDWARD
IPC: A61C19/06
Filed: 2002-07-31
Abstract: An apparatus for whitening teeth includes a source of oxidizing gas (12) and a handpiece (16) for delivering the gas to the tooth (40). A cup (34) attached to the handpiece is provided for receiving the gas and exposing a selected area of the tooth to the gas. The cup includes a resilient edge (44) for sealing the edge for engaging the tooth around the selected area to prevent escape of a gas.
Patent NZ-530828-A (NZ)
Title: Surfactant and their aerosol formulations for inhalation medicaments
Inventor: KALDOR ISTVAN
IPC: A61K31/56
Filed: 2002-08-02
Abstract: A pharmaceutical aerosol formulation comprising a particulate medicament, one or more fluorocarbon or hydrogen-containing chlorofluorocarbon propellants and [(7,7,8,8,8-pentafluorooctyl)oxy] acetic acid or a salt or solvate thereof is disclosed. The use of [(7,7,8,8,8-pentafluorooctyl)oxy] acetic acid as a surfactant or a suspending agent in a pharmaceutical aerosol suspension adapted for use in a metered dose inhaler is also disclosed.
Patent NZ-536060-A (NZ)
Title: Wire twisting apparatus
Inventor: CARDWELL OLIVER RAYMOND
Filed: 2004-10-20
Abstract: A rotatable member (105) has an aperture (115) substantially aligned with an axis of rotation of the member and through which a first length of wire (2a) may extend. A recess (117) is provided in the member. An engagement surface (131) is associated with the recess. With a first length of wire (2a) extending through the aperture and a second length of wire (7) extending across and adjacent to the first length of wire, rotation of the rotatable member will cause the engagement surface (131) to engage with the second length of wire (7) and twist the second length of wire around the first length of wire (2a) to form a twisted wire joint at least substantially within the recess and which includes a plurality of full turns of the second length of wire around the first length of wire.
Patent NZ-537268-A (NZ)
Title: Method for the separation of triglycoalkaloids
Inventor: CARTER STEPHEN
IPC: C07H17/02
Filed: 2003-06-13
Abstract: A method for the separation of a rhamnose-glucose-galactose triglycoalkaloid and a rhamnose-rhamnose-glucose triglycoalkaloid from a mixture containing both the rhamnose-glucose-galactose triglycoalkaloid and the rhamnose-rhamnose-glucose triglycoalkaloid, the method comprising the steps of: Combining the mixture with a portion of alcoholic solvent; Causing or allowing a substantial portion of the rhamnose-rhamnose glucose triglycoalkaloid to dissolve, thereby generating an alcoholic solution substantially of the rhamnose-rhamnose-glucose triglycoalkaloid, and a solid substantially comprising the rhamnose-glucose-galactose triglycoatkaloid; and Separating the solid substantially comprising the rhamnose-glucose galactose triglycoalkaloid from the solution substantially of the rhamnose rhamnose-glucose triglycoalkaloid.
Patent NZ-538094-A (NZ)
Title: Serum free and animal protein free culture medium for cultivation of cells
Inventor: REITER MANFRED
IPC: C12N5/071
Filed: 2003-07-08
Abstract: Described is an animal protein free cell culture medium which is capable of supporting growth of animal cells. The culture medium comprises a purified soy hydrolysate in a concentration of between about 0.2% (w/v) to about 0.6% (w/v) and a purified yeast hydrolysate in a concentration of between about 0.05% (w/v) to about 0.2% (w/v) and at least 90% of the hydrolysates have a molecular weight of less than or equal to 1000 Daltons. Also described is a method of producing the animal protein free cell culture medium capable of supporting the growth of animal cells, a method of cultivating an animal cell culture, an animal protein confluent cell culture process, a culture of animal cells cultivated in the animal protein free medium and a method for producing a virus.
Patent NZ-538281-A (NZ)
Title: A down light protector arrangement
Inventor: CRAIG JULIA
IPC: F21V29/15
Filed: 2003-08-22
Abstract: The disclosure relates to a protector arrangement for a downlight. In one embodiment, the protector arrangement is arranged for use with a downlight having a transformer (18). The protector arrangement includes housing means arranged to be located relative to a surface of a wall or ceiling, and to shield the components of the downlight. The housing extends beyond the surface into a wall or ceiling space when the downlight is mounted in the wall or ceiling. The protector arrangement also includes means for locating the transformer so that the transformer is protected from direct contact with any material in the wall or ceiling space.
Patent NZ-540743-A (NZ)
Title: Preparation of antifreeze protein
Inventor: CHAPMAN JOHN WILLIAM
IPC: C12P1/02
Filed: 2003-11-03
Abstract: Provided is a method for producing a type III antifreeze protein (AFP) comprising expressing in a fungal host cell which is deficient in glycosylation of type III AFP in comparison to the parent strain, a nucleic acid sequence encoding the AFP, wherein the fungal cell is a yeast which is a pmt1- and/or pmt2-deficient mutant strain. The yeast can be Saccharomyces cerevisiae.
Patent NZ-542904-A (NZ)
Title: Antifungal nail coat and method of use
Inventor: KEPKA STANLEY W
IPC: A61Q3/02
Filed: 2004-03-22
Abstract: Disclosed is a dual-action, one coat type anti fungal nail coat composition comprising on a total composition weight basis: terbinafine hydrochloride present in an amount in the range of 0.5 to 10 weight percent; dodecyl-2-(N,N-dimethylamino) isopropionate hydrochloride (DDAIP.HCl) present in an amount in the range of 0.1 to 25 weight percent; benzyl alcohol present in an amount in the range of 0.1 to 10 weight percent ; polyvinylpyrrolidone present in an amount in the range of 0.1 to 5 weight percent; and the remainder ethanol.
Patent NZ-553114-A (NZ)
Title: Collapsible boat hull
Inventor: AGER GAVIN RONALD
Filed: 2005-08-12
Abstract: A collapsible boat hull comprising: a pair of bottom panels, each having a first continuous hinge along its inner edge and a second continuous hinge along its outer edge; a pair of side panels, each being connected to a bottom panel by the respective second continuous hinge; a stern member; and a seat. The seat provides a brace between the stern member and the side panels such that force and vibration from an outboard motor is transferred through the seat to the side panels.
Patent NZ-566271-A (NZ)
Title: Method of preparing esomeprazole and salts thereof
Inventor: HA TAE HEE
IPC: C07D401/12
Filed: 2006-07-11
Abstract: Disclosed is a method of preparing optically pure esomeprazole and its salt, which comprises dissolving (S)-(-)-binol, a weak base and the racemic form of omeprazole in a mixture of a water-compatible organic solvent and water at a temperature ranging from 30 to 70 Deg. C, cooling the mixed solution to a temperature of -5 Deg. C to room temperature to allow the crystallization of the inclusion complex of esomeprazole and (S)-(-)-binol, and removing the (S)-(-)-binol moiety from the crystallized inclusion complex by filtration or extraction.
Patent NZ-568660-A (NZ)
Title: Dishwasher with the feed device adjacent to a surround in the door and in the centre of the door
Inventor: HARTMANN MICHAEL
IPC: A47L15/44
Filed: 2006-11-28
Abstract: A door (1) for a dishwasher, in particular for a domestic dishwasher, serves for opening and closing the interior of the dishwasher, comprising an inner door (2) which, in the closed state of the door (1), is oriented towards the interior and has a surround (3) comprising a top and a bottom periphery (3a, 3b), which run essentially horizontally in the closed state of the door (1), and two side peripheries (3c, 3d), which run essentially vertically in the closed state of the door (1), characterized in that a feed device for dispensing additives is arranged on the inner door (2), essentially centrally between the side peripheries (3c, 3d) and in the top third, in particular in the top quarter, of the region between the top and bottom peripheries (3a, 3b). The inner door within the surround has an outward bulge which in the region of the feed device slopes towards the upper edge of the surround.
Patent NZ-570463-A (NZ)
Title: Plasma coated laboratory equipment and consumables
Inventor: COULSON STEPHEN
IPC: B05D7/00
Filed: 2007-01-19
Abstract: A laboratory consumable having a polymeric coating, formed by exposing said consumable to pulsed plasma comprising a compound of formula (I), wherein the variables are as defined in the specification, for a sufficient period of time to allow a polymeric layer to form on the surface of the laboratory consumable; wherein the laboratory consumable is selected from pipette tips, filtration membranes, microplates immunoassay products, centrifuge tubes, microtubes, specimen tubes, test tubes, blood collection tubes, flat based tubes, aseptically produced containers, burettes, curvettes, needles, hypodermic syringes, sample vials/bottles, screw cap containers, or weighing bottles. Particularly preferred compound of formula (I) is 1H, 1H, 2H, 2H-heptadecafluorodecyl acrylate. Laboratory consumable of this type show significantly reduced liquid sample retention, maximum sample recovery and ultra non-binding properties, as well as oil and water-repellency.
Patent NZ-573790-A (NZ)
Title: Bituminous products and aqueous emulsions based on bituminous products which comprise a polyethyloxide / polypropylene oxide copolymer such as pluronic l122 or pluronic f127
Inventor: BARRETO GILLES
IPC: C08L71/03
Filed: 2007-06-06
Abstract: Disclosed is a bituminous product which comprises as an essential additive a random or block ethylene oxide / propylene oxide copolymer which has a molecular weight of between 500 and 20,000 g/mol, and a monomer weight ratio of ethylene oxide to total monomer content of between 1% and 70% (and includes those polymers which are known under the names or Pluronic L122 or Pluronic F127) and wherein the ethylene oxide / propylene oxide copolymer comprises between 0.01 and 0.9% of the total weight of the bituminous product.
Patent NZ-580516-A (NZ)
Title: Crystalline forms of topotecan hydrochloride and processes for making the same
Inventor: HU TSUNG-CHENG
IPC: A61K31/4745
Filed: 2008-04-14
Abstract: Disclosed is a crystalline Form D of topotecan hydrochloride characterized by a powder X-ray diffraction pattern having peaks at 5.9, 13.9, 22.6, 23.2 and 26.5 o20 (+0.2o). Further disclosed is a process for preparing the topotecan hydrochloride as described above comprising: (a) dissolving topotecan hydrochloride in a first solvent system; (b) adjusting the pH of the resulting mixture of step (a) to below 1.2; c) adding a volume of low polar solvent into the mixture of step (b) to form a second solvent system, wherein the first solvent system is more polar than the second solvent system; and (d) crystallizing the topotecan hydrochloride Form D from the second solvent system.